Cylene Pharmaceuticals' Series B Round

Cylene Pharmaceuticals raised a round of funding on February 23, 2005.

Cylene Pharmaceuticals is a clinical-stage, private company developing small molecule drugs against newly validated cancer targets. Cylene has taken a position in the discovery and development of firs…

Articles about Cylene Pharmaceuticals' Series B Round: